Results for “Diagnostics and Prognostics Group”

DOE OSTI2026

Diagnostics, Prognostics, and Optimization for Lithium-Ion Battery Systems

Health management of lithium-ion battery systems presents a host of challenges due to their complex physics, large numbers of components, and a wide variety of degradation behaviors across different battery types. Dr. Paul Gasper will present on research from the Electrochemical Energy Storage Group on Lithium-ion battery diagnostics, prognostics, and optimization. Diagnostics research, including state-estimation via machine-learning from electrochemical impedance spectroscopy and DC pulses as well as continuous state-estimation via Kalman filters, will highlight the ongoing challenges for accurately measuring the state of batteries without performing time-consuming characterization tests. NLR's industry-recognized battery prognostics work, which predicts real-world battery degradation by identifying degradation rate models from accelerated aging data using statistical modeling and machine-learning, will be used to demonstrate the critical impact of battery controls, thermal management, and operating strategy on durability and lifetime. Finally, the use of prognostic models for financial or lifetime optimization will be discussed.

25 ENERGY STORAGE↗

DOE OSTI2024

Steroid responsiveness in alcohol-associated hepatitis is linked to glucocorticoid metabolism, mitochondrial repair, and heat shock proteins

Alcohol-associated hepatitis (AH) is one of the clinical presentations of alcohol-associated liver disease. AH has poor prognosis, and corticosteroids remain the mainstay of drug therapy. However, ~40% of patients do not respond to this treatment, and the mechanisms underlying the altered response to corticosteroids are not understood. The current study aimed to identify changes in hepatic protein expression associated with responsiveness to corticosteroids and prognosis in patients with AH. Patients with AH were enrolled based on the National Institute on Alcohol Abuse and Alcoholism inclusion criteria for acute AH and further confirmed by a diagnostic liver biopsy. Proteomic analysis was conducted on liver samples acquired from patients with AH grouped as nonresponders (AH-NR, n = 7) and responders (AH-R, n = 14) to corticosteroids, and nonalcohol-associated liver disease controls (n = 10). The definition of responders was based on the clinical prognostic model, the Lille Score, where a score < 0.45 classified patients as AH-R and a score > 0.45 as AH-NR. Primary outcomes used to assess steroid response were Lille Score (eg, improved liver function) and survival at 24 weeks. Reduced levels of the glucocorticoid receptor and its transcriptional co-activator, glucocorticoid modulatory element-binding protein 2, were observed in the hepatic proteome of AH-NR versus AH-R. The corticosteroid metabolizing enzyme, 11-beta-hydroxysteroid dehydrogenase 1, was increased in AH-NR versus AH-R along with elevated mitochondrial DNA repair enzymes, while several proteins of the heat shock pathway were reduced. Analysis of differentially expressed proteins in AH-NR who survived 24 weeks relative to AH-NR nonsurvivors revealed several protein expression changes, including increased levels of acute phase proteins, elevated coagulation factors, and reduced mast cell markers. This study identified hepatic proteomic changes that may predict responsiveness to corticosteroids and mortality in patients with AH.

59 BASIC BIOLOGICAL SCIENCES↗